Markston International LLC cut its stake in shares of UnitedHealth Group Inc. (NYSE:UNH) by 9.9% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 22,668 shares of the healthcare conglomerate’s stock after selling 2,499 shares during the period. Markston International LLC’s holdings in UnitedHealth Group were worth $3,201,000 as of its most recent filing with the SEC.
Several other hedge funds have also bought and sold shares of the stock. MCF Advisors LLC boosted its position in shares of UnitedHealth Group by 312.9% in the first quarter. MCF Advisors LLC now owns 958 shares of the healthcare conglomerate’s stock valued at $123,000 after buying an additional 726 shares in the last quarter. Benjamin F. Edwards & Company Inc. boosted its position in shares of UnitedHealth Group by 91.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,082 shares of the healthcare conglomerate’s stock valued at $153,000 after buying an additional 518 shares in the last quarter. Evanson Asset Management LLC purchased a new position in shares of UnitedHealth Group during the second quarter valued at about $201,000. Parametrica Management Ltd purchased a new position in shares of UnitedHealth Group during the second quarter valued at about $201,000. Finally, Franklin Street Advisors Inc. NC purchased a new position in shares of UnitedHealth Group during the second quarter valued at about $208,000. 85.78% of the stock is owned by institutional investors and hedge funds.
UnitedHealth Group Inc. (NYSE:UNH) traded down 1.08% on Monday, hitting $138.49. The company had a trading volume of 2,724,399 shares. The firm’s 50 day moving average price is $138.30 and its 200 day moving average price is $136.18. The stock has a market cap of $131.90 billion, a P/E ratio of 21.67 and a beta of 0.57. UnitedHealth Group Inc. has a 12-month low of $107.51 and a 12-month high of $144.48.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.89 by $0.07. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The business had revenue of $46.50 billion for the quarter, compared to the consensus estimate of $45.05 billion. Equities analysts predict that UnitedHealth Group Inc. will post $7.90 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were paid a $0.625 dividend. This represents a $2.50 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date of this dividend was Tuesday, September 6th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 39.12%.
UNH has been the subject of several research reports. Leerink Swann reaffirmed an “outperform” rating on shares of UnitedHealth Group in a report on Sunday, August 21st. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $178.00 price objective on shares of UnitedHealth Group in a report on Tuesday, September 6th. Royal Bank Of Canada lifted their price objective on UnitedHealth Group from $157.00 to $165.00 and gave the stock an “outperform” rating in a report on Wednesday, July 20th. Credit Suisse Group AG reaffirmed a “buy” rating and set a $148.00 price objective on shares of UnitedHealth Group in a report on Wednesday, June 29th. Finally, Zacks Investment Research cut UnitedHealth Group from a “hold” rating to a “sell” rating in a report on Monday, July 18th. One investment analyst has rated the stock with a hold rating, twenty-four have given a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $154.96.
In other news, Director Richard T. Burke sold 40,000 shares of the company’s stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the transaction, the director now directly owns 2,003,550 shares of the company’s stock, valued at $271,100,350.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 1.65% of the stock is currently owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.